Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Nicklas, W., Kraft, V., Meyer, B. 1993. Contamination of transplantable tumors, cell-lines and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296–300.

    CAS  PubMed  Google Scholar 

  2. 2

    Minor, P. 1993. Virological aspects of the quality control of human monoclonal antibodies, International Association of the Biological Standardization, Developments in biological standardization, S. Karger AG, Basel :233–236.

  3. 3

    Trijzelaar, B. 1993. Regulatory affairs and biotechnology in Europe. III. Introduction into good regulatory practice: Validation of virus removal and inactivation. Biotherapy 6: 93–102.

    CAS  Article  Google Scholar 

  4. 4

    Frommer, W. et al. 1993. Safe biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogens. Appl. Microbiol. Biotechnol. 39: 141–147.

    CAS  Article  Google Scholar 

  5. 5

    EEC Regulatory Document—Note for guidance—Validation of virus removal and inactivation procedures. 1991. Biologicals 19: 247–251.

    Article  Google Scholar 

  6. 6

    Webster, R.G. and Granoff, A. 1994. Encyclopedia of virology: Vol. 1–3. Academic Press, London.

    Google Scholar 

  7. 7

    Tateishi, J. et al. 1993 Removal of causative agent of Creutzfeldt-Jakob-disease (CJD) through membrane filtration method. Membrane 18: 357–362.

    Article  Google Scholar 

  8. 8

    Prusiner, S.B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144.

    CAS  Article  Google Scholar 

  9. 9

    Roitt, I.M., Brostoff, J., Male, D.K., 1991 Lehrbuch der Immunologie. Georg Thieme Verlag, Stuttgart.

  10. 10

    DiLeo, A.J. and Allegrezza, A.E. 1991 Validatable virus removal from protein solutions. Nature 351: 420–421.

    CAS  Article  Google Scholar 

  11. 11

    Tsurumi, T., Osawa, N., Hitaka, H., and Hirasaki, T. 1990. Structure of cuprammonium regenerated cellulose hollow fiber (BMM hollow fiber) for virus removal. Polym. J. 22: 751–758.

    CAS  Article  Google Scholar 

  12. 12

    White, E.M., Grun, J.B., Sun, C.-S., and Sito, A.F. 1991. Process validation for virus removal and inactivation. Reprinted from Biopharm.

  13. 13

    Hamamoto, Y. et al. 1989. A novel method for removal of human immunodeficiency virus: Filtration with porous polymeric membranes. Vox Sang 56: 230–236.

    CAS  Article  Google Scholar 

  14. 14

    Tsuboi, T. et al. 1992. Combination of virus removal and inactivation for the process validation of bio-drugs. Murakami.H., Shirahata, S., Tachibana, H., Animal cell technology: Basic and applied aspects, Kluwer Academic Publishers, Dordrecht :289–294.

    Google Scholar 

  15. 15

    Burnouf-Radosevich, M., Appourchaux, P., Huart, J.J., and Burnouf, T. 1994. a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates. Vox Sang. 67: 132–138.

    CAS  Article  Google Scholar 

  16. 16

    Manabe, S. et al. 1991. Elimination of microorganisms from cell culture medium using regenerated cellulose hollow fiber (BMM). Sasaki, R. & Ikura, K., Animal Cell Culture and Production of Biologicals, Kluwer Academic Publishers, Dordrecht: 87–94.

    Google Scholar 

  17. 17

    Tomokiyo, K. et al. 1991. Studies on virus elimination and inactivation effects of highly purified factor VIII concentrates. Jpn. Clin. Rep. 25: 1–8.

    Google Scholar 

  18. 18

    Sekiguchi, S. et al. 1989. Possibility of hepatitis B virus removal from human plasma using regenerated cellulose hollow fiber (BMM). Membrane 14: 77–83.

    Article  Google Scholar 

  19. 19

    Yasua, T. et al. 1991. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J. Gen. Virolog. 72: 2021–2024.

    Article  Google Scholar 

  20. 20

    EC note for guidance: Validation of virus removal and inactivation procedures. 1991. Pharmacol. Toxicol. 69: 144–148.

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Maerz, H., Hahn, S., Maassen, A. et al. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration. Nat Biotechnol 14, 651–652 (1996).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing